Healthcare provider profile · identity verified

Daniel John Dudrick, M.D.

Family Practice · MOUNTAIN TOP, PA · NPI 1003825506

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	723	171
Atorvastatin Calcium	Atorvastatin Calcium	697	177
Rosuvastatin Calcium	Rosuvastatin Calcium	498	112
Hydrochlorothiazide	Hydrochlorothiazide	399	85
Lisinopril	Lisinopril	399	90
Losartan Potassium	Losartan Potassium	384	89
Metformin Hcl	Metformin Hcl	373	89
Levothyroxine Sodium	Levothyroxine Sodium	337	77
Olmesartan Medoxomil	Olmesartan Medoxomil	279	57
Alendronate Sodium	Alendronate Sodium	262	49
Metoprolol Succinate	Metoprolol Succinate	247	60
Famotidine	Famotidine	206	45
Glipizide Er	Glipizide	199	47
Simvastatin	Simvastatin	198	46
Tamsulosin Hcl	Tamsulosin Hcl	193	51
Pantoprazole Sodium	Pantoprazole Sodium	185	34
Pravastatin Sodium	Pravastatin Sodium	179	44
Fluticasone Propionate	Fluticasone Propionate	173	66
Sertraline Hcl	Sertraline Hcl	146	37
Valsartan	Valsartan	142	30
Synthroid	Levothyroxine Sodium	135	28
Eliquis	Apixaban	129	20
Omeprazole	Omeprazole	128	31
Metoprolol Tartrate	Metoprolol Tartrate	117	24
Potassium Chloride	Potassium Chloride	102	19
Paroxetine Hcl	Paroxetine Hcl	101	17
Irbesartan	Irbesartan	99	20
Clopidogrel	Clopidogrel Bisulfate	94	18
Albuterol Sulfate Hfa	Albuterol Sulfate	91	46
Escitalopram Oxalate	Escitalopram Oxalate	88	21
Metformin Hcl Er	Metformin Hcl	88	18
Allopurinol	Allopurinol	83	21
Duloxetine Hcl	Duloxetine Hcl	83	17
Gabapentin	Gabapentin	83	21
Furosemide	Furosemide	81	22
Ozempic	Semaglutide	68	16
Donepezil Hcl	Donepezil Hcl	67	12
Montelukast Sodium	Montelukast Sodium	66	12
Atenolol	Atenolol	65	17
Jardiance	Empagliflozin	61	14
Clonidine Hcl	Clonidine Hcl	59	16
Alprazolam	Alprazolam	58	15
Labetalol Hcl	Labetalol Hcl	57	suppressed
Ezetimibe	Ezetimibe	55	14
Lorazepam	Lorazepam	54	suppressed
Glimepiride	Glimepiride	53	13
Doxazosin Mesylate	Doxazosin Mesylate	52	11
Carvedilol	Carvedilol	50	16
Chlorthalidone	Chlorthalidone	48	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	46	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	45	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	suppressed
Memantine Hcl	Memantine Hcl	42	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	42	suppressed
Januvia	Sitagliptin Phosphate	38	suppressed
Azelastine Hcl	Azelastine Hcl	34	19
Spironolactone	Spironolactone	32	suppressed
Terazosin Hcl	Terazosin Hcl	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Enalapril Maleate	Enalapril Maleate	29	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	23
Clonazepam	Clonazepam	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	21
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	21
Celecoxib	Celecoxib	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	21
Finasteride	Finasteride	23	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	17
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Rybelsus	Semaglutide	19	suppressed
Trazodone Hcl	Trazodone Hcl	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Prednisone	Prednisone	17	14
Benazepril Hcl	Benazepril Hcl	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Colchicine	Colchicine	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Azithromycin	Azithromycin	14	14
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	11
Dilt-Xr	Diltiazem Hcl	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Torsemide	Torsemide	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Indapamide	Indapamide	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Nexletol	Bempedoic Acid	12	suppressed
Perphenazine	Perphenazine	12	suppressed
Primidone	Primidone	12	suppressed
Ramelteon	Ramelteon	12	suppressed
Ramipril	Ramipril	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Repaglinide	Repaglinide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error